AGM
Alpine Global Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,536
| Closed | -$1.49M | – | 254 |
|
|
2024
Q4 | $1.49M | Buy |
+16,536
| New | +$1.49M | 0.19% | 84 |
|
|
2024
Q3 | – | Sell |
-6,599
| Closed | -$612K | – | 480 |
|
|
2024
Q2 | $612K | Buy |
+6,599
| New | +$612K | 0.11% | 160 |
|
|
2022
Q1 | – | Sell |
-52,818
| Closed | -$6.58M | – | 736 |
|
|
2021
Q4 | $6.58M | Buy |
+52,818
| New | +$6.58M | 0.97% | 15 |
|
|
2021
Q3 | – | Sell |
-30,052
| Closed | -$4.07M | – | 374 |
|
|
2021
Q2 | $4.07M | Buy |
+30,052
| New | +$4.07M | 0.55% | 42 |
|
|
2020
Q4 | – | Sell |
-26,340
| Closed | -$2.94M | – | 308 |
|
|
2020
Q3 | $2.94M | Buy |
+26,340
| New | +$2.94M | 0.61% | 25 |
|
|
2020
Q1 | – | Sell |
-4,499
| Closed | -$428K | – | 448 |
|
|
2019
Q4 | $428K | Sell |
4,499
-1,379
| -23% | -$131K | 0.09% | 186 |
|
|
2019
Q3 | $448K | Sell |
5,878
-797
| -12% | -$60.7K | 0.11% | 44 |
|
|
2019
Q2 | $585K | Buy |
+6,675
| New | +$585K | 0.17% | 43 |
|
|
2018
Q3 | – | Sell |
-4,804
| Closed | -$457K | – | 97 |
|
|
2018
Q2 | $457K | Buy |
+4,804
| New | +$457K | 0.22% | 42 |
|
|
2017
Q4 | – | Sell |
-7,827
| Closed | -$678K | – | 284 |
|
|
2017
Q3 | $678K | Buy |
+7,827
| New | +$678K | 0.2% | 78 |
|
|
2017
Q2 | – | Sell |
-8,279
| Closed | -$574K | – | 326 |
|
|
2017
Q1 | $574K | Buy |
+8,279
| New | +$574K | 0.15% | 115 |
|
|
2016
Q2 | – | Sell |
-5,801
| Closed | -$300K | – | 255 |
|
|
2016
Q1 | $300K | Buy |
+5,801
| New | +$300K | 0.07% | 93 |
|
|
2015
Q4 | – | Sell |
-17,945
| Closed | -$1.12M | – | 147 |
|
|
2015
Q3 | $1.12M | Buy |
17,945
+15,428
| +613% | +$960K | 0.33% | 31 |
|
|
2015
Q2 | $635K | Buy |
+2,517
| New | +$635K | 0.11% | 152 |
|